Who to call at Physiomics plc, and when
Fundz watches for the moments Physiomics plc starts buying, and tells you who to reach.
- An alert the day Physiomics plc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Physiomics plc, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Physiomics plc. With Fundz connected, it knows.
Contract Type
contract
United KingdomBiotechnologyHealth CareDescription
Physiomics has secured a new contract for model-informed drug development work, expanding its cumulative contract awards to exceed last year's revenue. This contract focuses on pharmacokinetic and pharmacodynamic modelling, enhancing the company's service offerings to drug developers.
Quick answer
Physiomics Wins New Contract for Drug Development Modelling Services (November 4, 2026). Physiomics plc is based in United Kingdom.
- What agreement did Physiomics plc announce on November 4, 2026?
- Physiomics has secured a new contract for model-informed drug development work, expanding its cumulative contract awards to exceed last year's revenue. This contract focuses on pharmacokinetic and pharmacodynamic modelling, enhancing the company's service offerings to drug developers.
- What does Physiomics plc do?
- Physiomics plc is a leading mathematical modelling, data science, and biostatistics company.
- Where is Physiomics plc based?
- Physiomics plc is based in United Kingdom.
- Which similar companies announced contracts around the same time?
- Nxera Pharma (November 4, 2026), JD Technologies Global (November 4, 2026), Wildcat DX (November 4, 2026) and Evommune (November 4, 2026) also announced agreements within 45 days of Physiomics plc.
Source: Fundz verified event record.
Other recent agreements in Biotechnology and Health Care
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- AbbVie secures exclusive licensing rights to Nxera’s EP4 program for inflammatory bowel disease with a $100 million payment. (November 4, 2026)
- JD Technologies Global and FRIWO North America Form Strategic Partnership to Enhance U.S. Medical Market Access (November 4, 2026)
- Wildcat Defense partners with Taqtile to deploy digital tools in shipyards. (November 4, 2026)
- Evommune Enters Exclusive License Agreement with Hinova Pharmaceuticals (November 4, 2026)
- Teva and Samsung Bioepis Sign Agreement for U.S. Rights to Biosimilars Infliximab and Etanercept. (November 3, 2026)
- Kimia Therapeutics and CStone Pharmaceuticals Collaborate on Clinical Development of KT-721 for Oncology Treatment. (November 5, 2026)
Physiomics plc signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.